Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions
© Alkhalil et al; licensee BioMed Central Ltd. 2008
Received: 7 May 2010
Accepted: 28 July 2010
Published: 28 July 2010
Monkeypox virus (MPV) is a zoonotic Orthopoxvirus and a potential biothreat agent that causes human disease with varying morbidity and mortality. Members of the Orthopoxvirus genus have been shown to suppress antiviral cell defenses, exploit host cell machinery, and delay infection-induced cell death. However, a comprehensive study of all host genes and virus-targeted host networks during infection is lacking. To better understand viral strategies adopted in manipulating routine host biology on global scale, we investigated the effect of MPV infection on Macaca mulatta kidney epithelial cells (MK2) using GeneChip rhesus macaque genome microarrays. Functional analysis of genes differentially expressed at 3 and 7 hours post infection showed distinctive regulation of canonical pathways and networks. While the majority of modulated histone-encoding genes exhibited sharp copy number increases, many of its transcription regulators were substantially suppressed; suggesting involvement of unknown viral factors in host histone expression. In agreement with known viral dependence on actin in motility, egress, and infection of adjacent cells, our results showed extensive regulation of genes usually involved in controlling actin expression dynamics. Similarly, a substantial ratio of genes contributing to cell cycle checkpoints exhibited concerted regulation that favors cell cycle progression in G1, S, G2 phases, but arrest cells in G2 phase and inhibits entry into mitosis. Moreover, the data showed that large number of infection-regulated genes is involved in molecular mechanisms characteristic of cancer canonical pathways. Interestingly, ten ion channels and transporters showed progressive suppression during the course of infection. Although the outcome of this unusual channel expression on cell osmotic homeostasis remains unknown, instability of cell osmotic balance and membrane potential has been implicated in intracellular pathogens egress. Our results highlight the role of histones, actin, cell cycle regulators, and ion channels in MPV infection, and propose these host functions as attractive research focal points in identifying novel drug intervention sites.
Monkeypox virus is a double-stranded DNA virus and one of the human pathogenic orthopoxviruses that include Variola (VARV), cowpox (CPX), and Vaccinia (VACV) viruses. The virus causes a disease that manifests similarly to smallpox, but with milder morbidity and lower mortality rates . Variation in MPV virulence has been observed and mapped to defined geographic origins, e.g., virus isolates from Central Africa are more virulent than those from Western Africa [2, 3]
Recent advances in molecular biology and genomics have improved our understanding of viral infection and replication mechanisms. Monkeypox virus has a relatively large genome of about 196,858 base pairs, encoding 190 open reading frames, which constitute the bulk of the material needed for viral replication in cell cytoplasm . Viral entry into cells is dependent on cell type and viral strain, and occur after an initial attachment to cell surface through interactions between multiple viral ligands and cell surface receptors  such as chondroitin sulfate  or heparan sulfate [7, 8]. Subsequent crossing of cell membrane is mediated by a viral fusion event with cell membrane under neutral pH conditions , or by endosomal uptake via a macropinocytosis-like mechanism that involves actin [10, 11] and low pH-dependent steps . Once in the cell cytoplasm, the virus releases prepackaged viral proteins and enzymatic factors that disable cell defenses and stimulate expression of early genes [13–15]. Synthesis of early proteins promotes further uncoating, DNA replication, and production of intermediate transcription factors. In following stage, intermediate genes are transcribed and translated to induce the expression of late genes that function mainly as structural proteins, enzymes, and early transcription factors. Eventually, membrane structures will appear and unit virion genomes processed from DNA concatemers are assembled into nascent virions that contain all enzymes, factors, and genetic information needed for a new infectious cycle.
The detailed available information about viral gene functions and its programmed expression during infection exceeds current knowledge of corresponding events in the host. Furthermore, although poxviruses are considered one of the most self-sufficient viral families, they remain unable to reproduce in extracellular environment and known to have limited host range, which suggest dependence on host elements [16, 17]. Therefore, identification of these specific host elements and pathways that are essential for viral replication will enrich our knowledge of host response to viral infection, and may prove valuable in identifying potential targets for antiviral therapies.
Microarrays have been used in genome exploration and profiling with special focus on understanding dynamics of viral gene expression and pathogenesis [18, 19]. However, a paucity of work employed this tool in examining host response to infections with poxviruses generally [20–22], and more specifically in the case of MPV. Because combining microarray technology with modern data mining tools allows further information extraction at genome-wide levels, we used whole genome rhesus macaque microarrays in combination with Ingenuity Pathways Analysis (Ingenuity® Systems, http://www.ingenuity.com) to investigate the effect of MPV infection on host Maccaca mulata kidney epithelial cells transcriptome, and address gaps in host response during MPV infection. Functional and canonical pathway analysis of differentially expressed genes at 3 and 7 hours post-infection (hpi) time points validated many of the known host gene responses to poxvirus infection and introduced new sets of interesting functions and pathways in areas of cell death and apoptosis, actin dynamics, ion channels and transport, and cell cycle regulation. Our data points to a vital role for these cell functions in MPV infection, and hence, signify their value in poxviruses' infection diagnosis and treatment studies.
Materials and methods
Cell culture and viral infection
Monkeypox virus-Katako Kombe strain (MPV-KK) was propagated in Vero E6 cells maintained in Eagle's Minimum Essential Medium with non-essential amino acids (EMEM/NEAA) supplemented with 2 mM L-glutamine, 10% heat-inactivated fetal bovine serum (FBS), 10 mg/L Gentamycin, 250 μg/L Fungizone, and buffered at pH 7.4 with 10 mM HEPES . Viral titers were determined by the plaque assay . As described previously , monolayer of Vero E6 were inoculated with serial dilutions of viral suspension and allowed to adsorb for 30 min at room temperature. The viral inoculate was removed and cells were washed twice with PBS then incubated with culture medium for 5 days. To count plaques, culture medium was removed and cells were fixed and stained simultaneously using 30% formalin, 5% ethanol (vol/vol) solution containing 1.3 g/L crystal violet.
For time points and control samples, MK2 cells were grown in the same culture medium described above but in absence of antibiotics and Fungizon for at least 2 days before infection with MPV. Culture medium was removed and cells were inoculated with crude monkeypox virus-Katako Kombe strain (MPV-KK) at MOI of 3. Virus was adsorbed for 30 min at 37°C with gentle rocking for 15 sec each 10 min, then cells were washed twice with room temperature equilibrated PBS, fresh culture medium was added, and cells were incubated for 3 or 7 hours. Control cells were handled identically except for exposure to virus.
RNA and cDNA preparation, labeling, hybridization, and scanning
RNA was extracted using TRIzol LS (Invitrogen) according to the manufacturer's recommended protocol. Briefly, 200 μl of chloroform (Sigma Aldrich, St. Louis, MI) was added to 5×106 infected and non-infected control cells harvested in 1 ml of TRIzol LS reagent (Invitrogen). Solutions were mixed thoroughly and incubated for 10-15 min at 4°C, then centrifuged for 20 min at 14,000 rpm in 4°C. After centrifugation, the aqueous phase was removed, added to an equal volume of 2-propanol (Sigma-Aldrich). After overnight incubation at -20°C, the mixture was centrifuged for 20 min at 14,000 rpm in 4°C. Supernatant was removed and the RNA pellet was washed with 80% ethanol (Sigma Aldrich), dried, and dissolved in 100 μl of RNase-free water (Ambion, Austin, TX). Possibly present contaminating DNA was eliminated using Turbo DNA-free kit (Ambion), and RNA clean up was performed using RNeasy kit (Qiagen, Valencia, CA). Quality and quantity of RNA was evaluated using Experion automated electrophoresis station and Experion RNA StdSens analysis kit (Bio-Rad, Hercules, CA). Clean sharp peaks representing intact rRNA were confirmed for each preparation by two independent workers.
cDNA was synthesized using One-cycle cDNA Synthesis kit (Affymetrix, Santa Clara, CA) in presence of poly-A RNA controls. Double-stranded cDNA samples were cleaned up and biotin labeling of antisense cRNA was carried out with the IVT Labeling Kit (Affymetrix, P/N 901229). Material was cleaned up then fragmented before hybridization overnight. Microarrays (Affymetrix, P/N 900656) were scanned using the Affymetrix GeneChip scanner following standard Affymetrix protocols  after carrying out all washing and staining steps as recommended by the manufacturer.
Microarray validation by RT PCR
RT PCR was performed utilizing the Superarray human common cytokines panel (PAHS-021E-4, Superarray, Frederick MD, 21703). Reactions were performed according to manufacturer's guidelines for both time points in 10 μl volumes using the 384 plate format that allow gene expression analysis in quadruplicate. Results showed a strong correlation of gene expression levels with that obtained using microarray.
The Affymetrix CEL files were imported into GeneSpring GX software v 7.3.1 (Agilent), which allows multi-filter comparisons using data from different experiments, to perform the normalization, generation of restriction lists and functional classifications of the differentially expressed genes.
Normalization was applied in two steps: i) "per chip normalization" by which each measurement was divided by the 50th percentile of all measurements in its array; and ii) "per gene normalization" by which each treated sample was normalized against its respective control (mock-treated) sample.
The expression of each gene was reported as the ratio of the value obtained relative to the control condition after normalization of the data. Transcripts whose levels reproducibly changed were identified using one-way parametric analysis of variance with a P-value cutoff of 0.05 (false discovery rate of 5%). The changes in transcript levels are expressed as the fold change in signal between control and treated samples.
Two-dimensional clustering was carried out based on samples and genes for visualization and assessment of reproducibility in the profile of the significant genes across biological replicates.
To characterize and measure changes in transcriptome of cells infected with MPV, we infected 107Macaca mulatta kidney epithelial cells (MK2) and incubated them for 3 or 7 hpi. Cells were infected at high multiplicity to enhance infection probability and improve signal to noise ratio. Infected cells were washed after virus adsorption to reduce response to any biological factors in the seed, and to avoid an infection continuum that may desynchronize virus replication stages. We selected the two time points not to exceed 7 hpi to avoid possible entry into a second cycle of viral replication, and to minimize artifacts that might arise from cell lysis after viral maturation and release of intracellular components . We mock-infected a similar number of cells and used them as controls for each time point. The experiment was done in triplicate, and 47,000 rhesus macaque transcripts potentially present in purified RNA from each sample were interrogated by 52,000 probe sets/microarray.
MPV compromises host's biological activities with a dominating global downregulation
Up- and down-regulated genes exhibit varied temporal regulation distribution
Functional gene clusters
Functional distribution of differentially expressed genes at 3, 7 hpi time points
Gene function category
Number of genes
FC < 1.8
ligand-dependent nuclear receptor
G-protein coupled receptor
List of differentially expressed genes involved in histones dynamics in MPV- infected cells
Entrez Gene Name
F-box protein 11
protein arginine methyltransferase 3
MYST histone acetyltransferase 2
MYC binding protein 2
arginyl-tRNA synthetase 2, mitochondrial
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
nuclear receptor coactivator 3
cAMP responsive element binding protein 1
YY1 transcription factor
histone deacetylase 2
histone cluster 3, H2a
H1 histone family, member 0
histone cluster 1, H3i
histone cluster 1, H1d
histone cluster 1, H2bj
histone cluster 1, H2ad,1
histone cluster 4, H4
List of MK2 cell genes exhibited differential expression upon infection with MPV and encoded ion channels or related proteins
Entrez Gene Name
chloride channel 3
potassium large conductance calcium-activated channel, subfamily M, alpha member 1
potassium channel modulatory
sodium channel, nonvoltage-gated 1 alpha
potassium channel tetramerisation
domain containing 20
transient receptor potential cation
channel, subfamily C, member 1
calcium channel, voltage-dependent,
beta 3 subunit
sodium channel and clathrin linker 1
two pore segment channel 1
Canonical pathways analysis
To identify the effect of viral infection on major biological processes in the cell, we examined potential enrichment of all differentially expressed genes in known canonical pathways. The two data sets were analyzed using IPA library of canonical pathways. Genes exhibited ≥ 1.8 FC and associated with a canonical pathway in the Ingenuity pathways knowledge database were considered for the analysis. Both data sets contained 2,702 genes from which 2,281 genes had mapped identities. The number of genes eligible for pathway analysis was 680 and 1,134 genes for time point 3 and 7 hpi, respectively. The significance of the association between a subset of genes in data sets and the canonical pathway was measured in two ways: 1) ratio of the number of genes from the data set that mapped to the pathway divided by the total number of genes that mapped to the canonical pathway, and 2) Fischer's exact test P-value, which determines the probability of random association between the genes in the datasets and the canonical pathway.
The following analysis focuses on most relevant pathways that were identified with strong statistical support of P-values < 0.05 and ratio > 10% in either time point.
Molecular mechanisms of cancer (MMC)
MMC pathway can be triggered by diverse stimuli including hormones, growth factors, cytokines, and oncogenes. Each of these stimuli is capable of inducing a variety of biological processes relating to cancer, including cell cycle regulation and cell cycle checkpoints, which were recognized in our analysis as independent pathways, and therefore will be discussed separately. The majority of the genes specific to cancer mechanisms pathway are involved in apoptosis regulation. Identified modulation in expression patterns of these genes suggest signaling apoptosis in infected cells, e.g., Noxa or PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1) shows more than 44-fold upregulation at 7 h PI. This molecule inactivates the anti-apoptotic molecule Bcl2 (B-cell CLL/lymphoma 2)[27–29], which regulates mitochondrial membrane potential by controlling the voltage dependant anion channel (VDAC) [30–32], consequently increasing the mitochondrial membrane permeability and the release of cytchrome C that serves as a major apoptosis inducer . In addition to Bcl2 inactivation, the expression of Bcl2 gene itself exhibited a significant -2.83-fold suppression, which would enhance apoptosis signaling. Apoptosis-induced cysteine-aspartic acid peptidases (caspases) such as caspase 3, which enhance the degradation of Bcl2  and trigger subprograms for cell dismantling and removal, exhibited 3.2-fold upregulation. Caspase 7, 8, and 10 expression remained unchanged, and only caspase 6 , which functions as a downstream enzyme in the caspase activation cascade, showed mild -1.2 and -1.62 FC at 3, 7 hpi time points, respectively. Other pro-apoptotic genes like BBC3 (BcL2 binding component 3) or PUMA  and p21 protein (Cdc42/Rac)-activated kinase 2 or PAK2  showed similar suppression trend of -1.85 and -1.99 FC at 7 hpi, respectively.
Proteosomal degradation has been associated with apoptosis. Our results show a 4.05 FC upregulation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon NFKBIE, which mediates cytoplasmic sequestering of transcription factor and acts as a transcription repressor. The effect of NFKBIE upregulation on apoptosis is unclear because it was reported to exhibit a cell line dependence .
Cell division cycle 25 homolog A, B, and C expression showed a remarkable regulation; e.g., Cdc25, which plays a key role in promoting progress through S phase , showed 1.7 FC, while Cdc 25 B and C, which regulate and promote entry into mitosis [39, 40], exhibited -4.3 and -1.92 FC, respectively. Similarly, cyclin -dependent kinase regulators, cyclin E2 and cyclin D1, which are strongly tied to a variety of cancers [41–43], showed upregulation of 3.2 and 2.2 FC, respectively.
Other cell cycle regulators that have overlapping functions with apoptosis mechanisms showed sharp downregulation. This include members of the p21 RAS group such as KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) and Ras homolog or the RHO GTPase protein group including RHOB, RHOQ, RHOT1, and RND3 (Fig. 6).
Ephrine signaling pathway (ESP)
Two proteins were up-regulated in this pathway, ARPC5L (actin-related protein 2/3 complex, subunit 5-like), which functions as an actin-binding protein and is involved in regulation of actin filament polymerization  and GNAS complex locus, which is a member of G-protein alpha subunit that has an indirect effect on signaling of ephrine pathway. The importance of this pathway is due to its involvement in the modulation of integrin activity, actin reorganization, and cellular dynamics, which are all central to viral motility, exit and invasion of proximal cells.
Ataxia telangiectasia mutated protein signaling pathway
Pathways involved in cell cycle regulation
A significant proportion of the genes in data sets 3 and 7 hpi were enriched in three major cell cycle regulation pathways. Out of the 36 molecules found in cell-cycle regulation by BTG family pathway, seven molecules were found in each of the 3 and 7 hpi data sets with P-values of 8.15e-4 at 3 hpi and 1.48e-2 at 7 hpi indicating the involvement of this pathway in early time point. Essential genes to pathway signaling and G1 arrest were severely suppressed (Figure. 9A). Retinoblastoma 1 (Rb) and B-cell translocation gene-1 (BTG1) were downregulated in both time points and reached -9.26 and -15.86 FC by 7 hpi. Furthermore, cyclin D1 and cyclin E exhibited 4.18- and 2.77-fold increase at 3 hpi respectively, and remained upregulated to similar levels at 7 hpi time point. The products of these two genes function as regulators that inactivate the growth suppression activity of Rb indirectly by promoting CDK kinases [46–48]. Phosphorylation of Rb by CDK kinase inactivates its function, leading to the release of E2F and cell cycle progression [49, 50]. The net outcome of this pattern of gene expression in this pathway is cell cycle release from potential arrest in G1 phase and block of BTG1-induced apoptosis.
The third cell-cycle-related pathway identified in our analysis was the G2/M DNA damage checkpoint regulation pathway. About 14% of the total 43 molecules comprised in this pathway exhibited significant expression modulation upon infection at time point 3 hpi with P-value of 5.02e-2. Time point 7 hpi showed regulation of 20.9% of total pathway with P-value of 1.19e-3, implying a wider pathway role during later stage of infection. Progression of cell cycle into mitosis requires the activation of cell-division cycle-2 (Cdc2) by the rapid dephosphorylation of its tyrosine 15 (Tyr-15) via action of Cdc25 and subsequent binding to cyclin B [60, 61]. Damaged DNA during G2 phase triggers ATM and ataxia telangiectasia mutated and rad3-related (ATR) [62–64], which in turn activates two key kinases, Chk2 and Chk1[65, 66]. The latter kinase inhibits Cdc25B and Cdc25C which function as a phosphorylase that activate Cdc2 before binding to cyclin B and entry into mitosis . Our results showed that ATR/ATM, and Chk1, which activate sequentially in response to DNA abnormalities, exhibited no or only a subtle change in their expression in both time points, suggesting retention of their Cdc25B/C inhibitory effect as in non-infected cells. Three essential molecules needed for entry into mitosis exhibited substantial downregulation; Cdc25B/C and cyclin B exhibited -4.33, -1.91, -4.48 FC at 7 hpi and -1.81, -2.27, -1.71 FC at 3 hpi respectively. The observed regulation of these genes would intensify this checkpoint signaling leading to a further delay in entry into mitosis (Fig. 9C).
Apoptosis is a natural controlled cell death mechanism triggered by diverse stimuli to maintain tissue homeostasis and eliminate abnormal or infected cells . Because apoptosis represents an important part of antiviral host response, poxviruses developed numerous ways to target it and disrupt its function . Diverse anti-apoptotic viral strategies are identified in different poxviruses, e.g., Molluscum contagiosum virus (MCV) inhibits caspase-8 by expressing MC159 gene, which encodes a protein that binds procaspase-8 and Fas-associated death domain, thereby inhibiting death receptor-induced apoptosis mediated by Fas, TNF, or TRAIL receptors . MC066 gene encodes a protein with glutathione peroxidase-like function to convert oxygen-reactive species to neutral molecules, hence preventing apoptosis triggered by increased oxidative stress associated with infection . Little is known about apoptosis in cells infected with MPV, but related orthopoxviruses exhibit clear anti-apoptotic functions. Cowpox virus for instance expresses a protein that can block apoptosis in multiple ways. One of the most potent anti-apoptotic proteins is the cytokine response modifier A (CrmA) which inhibits caspase-8, caspase-10, and blocks garnzyme B-mediated apoptosis [72, 73]. Similarly, Vaccinia viruses use SPI-2 family protein member of serine protease inhibitors (serpins) encoded by B13R gene to block apoptosis induced by death receptors . The same virus inhibits apoptosis induced by RNA-dependent protein kinase (PKR) using specific PKR inhibitors encoded by E3L and K3L genes , and apoptosis induced by loss of mitochondria outer membrane potential by expression of F1L gene .
The presence of many viral proteins that block apoptosis at multiple points suggests that apoptosis is detrimental to viral survival. However, the observed downregulation of Bcl-2, PUMA, and PAK2 and upregulation of NOXA and caspase-3 with the negligible change in other apoptotic genes in our data is more consistent with apoptosis induction. Although many pathogens and viruses other than poxviruses are reported to promote apoptosis , it is unlikely that MPV will differ from other poxviruses in their common anti-apoptotic trend, and the observed divergence between the regulation of apoptosis-specific genes in MPV-infected cells and overall anti-apoptotic outcome seen in other poxvirus-infected cells suggests an anti-apoptotic viral mechanism that functions downstream of apoptosis induction in the host. MPV genes involved in blocking apoptosis remain unknown, but our data suggests the presence of an ortholog(s) of Vaccinia virus (F1L) gene in MPV, which acts directly on the mitochondria in Bcl-2 like manner.
Double-stranded DNA mammalian viruses have large genomes reaching 289 Kbp or few hundreds of micrometers in length as in the case of fowlpox virus . Compacting the genome is an indispensible biological task due to the rich negative charge and large size of DNA molecules. In eukaryotes, this was solved by wrapping DNA around a heterooctameric molecule composed of four dimerized, positively charged core histones to form nucleosomes. Further stability is brought about by linker histones that bind DNA laterally. Nucleosomes, in a nucleofilaments form or in a form of higher-order-structure assemblies, chromatin, play an essential role in the regulation of gene expression and chromatin remodeling via acetylation and deacetylation of the N-terminal histone tails protruding from nucleosomes. Viruses exhibit similar architecture in their DNA compaction. Staining vaccinia-infected cells with osmium ammine-SO2 revealed areas with concentrated viral DNA in two predominant DNA configurations varying depending on the level of viral synthetic activities. Encapsidated genomes exhibited a nucleosome structure like those observed in resting eukaryotes, which was in agreement with biochemical data showing the supercoiled organization of nucleoproteins extracted from Vaccinia viruses . On the other hand, like active cellular chromatin, non-encapsidated viral genomes exhibited extended DNA features . Similar variation in DNA density was observed in Herpes simplex viruses (HSV), another double stranded DNA virus, with two well described configurations of euchromatin or heterochromatin that correlated strongly with lytic or latent HSV infection stages, respectively. Generally, little is known about chromatin potential in poxviruses as an antiviral mechanism. Our results showed an interesting downregulation of five essential histone expression regulation factors and five enzymes regulating chromatin dynamics in MPV-infected cells. It is unclear if these results are part of the host response, which include chromatin-mediated silencing of the viral genome and activation of DNA damage , or part of the viral strategies to take over its host. However, our observation predicts an important role for histone expression, histone posttranslational modification, and dynamic exchanges of chromatin in host-poxvirus interactions. Recent work suggested a role for the viral A32L gene of Vaccinia virus in DNA packaging based on sequence similarities with the product of gene I of filamentous single-stranded DNA bacteriophages and the Iva2 gene of adenoviruses. Both of these genes are ATPases involved in DNA packaging. Additional Vaccinia genes that map to I6 or I1 telomere-binding proteins are believed to play roles in DNA packaging, because mutants of VACV in either of these two genes fail to exhibit normal DNA packaging at different morphogenesis stages. The sharp upregulation we observed in three out the four core histones, and the striking similarities in DNA compaction architecture observed in eukaryotes and some viruses, with absence of known poxvirus proteins that exhibit histone-like properties makes it tempting to hypothesize a role of host cell histones in viral DNA compaction and nucleosome formation, especially that similar involvement was described recently in simian virus 40 (SV40) DNA compaction 
Our analysis identified ephrin receptor pathway (ERP) as a major influenced pathway in infected cells. This might be due to either increased cell to cell communication by signaling through this receptor tyrosine kinases (RTK) family in response to infection, or to the presence of many pleiotropic genes that are found in ERP, and simultaneously have essential roles in cytoskeleton reorganization or actin polymerization. Intracellular viral motility and morphogenesis of Vaccinia virus into a cell-associated enveloped virion (CEV) and extracellular enveloped virions (EEV) forms are shown to be driven by interactions of host microtubules and Vaccinia A27L, A17L and A14L genes. Furthermore, egress of Vaccinia particles in EEV form and direct cell-to-cell virus dissemination is propelled by actin tail formation, which involves the interactions of Vaccinia transport genes, including A36R, F12L, and host proteins such as Src family kinases (SFK), Nck, WIP, N-WASP, Arp 2/3 to promote actin filaments nucleation. Actin polymerization produces microvilli at cell surface that lift CEV and project it on adjacent cells to finally deliver the virus with minimal exposure to host immune system. Our results confirm regulation of many principal signaling components involved in actin cytoskeletal dynamics, and introduce additional infection regulated genes with functions related to microtubules signaling. This includes intersectin 1 (SH3 domain protein) gene, which encodes a cytoplasmic membrane-associated protein that indirectly coordinates endocytic membrane traffic with the actin assembly machinery, Rho-effector ROCK1 serve a number of key cellular functions, such as morphological differentiation and cell motility which are closely associated with changes in cytoskeletal dynamics . Additionally, RAS p21 protein activator (GTPase activating protein) , v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog  and SOS2  are crucial genes in polymerization of actin filaments and cytoskeleton reorganization.
Ion channels represent an intriguing and novel class of genes that were impacted by MPV infection. We identified 10 genes encoding nine ion channels and a transporter that underwent increasing suppression during infection. Most of these channels localize to cell membrane, and collectively contribute to transport of all essential ions involved in maintenance of cell membrane potential and osmolarity homeostasis. While mechanisms of transport modulation have been described previously, as in the indirect consequences of Ras, Rho, and Rab small GTPases regulation , its effect on viral infections and global cell biology remain unclear except for a recent report describing the interaction of myxoma poxvirus protein M11L with mitochondrial permeability transition pore and its role in delaying apoptosis in host cells . The downregulation trend of channel expression identified here pose many intriguing questions, especially in the light of evolving evidence in support of ion channels role in virus release  and infected cells rupture .
Progression of the cell cycle is tightly regulated process with many redundant checkpoints that ensure proper transition across cell cycle phases. Our results showed significant modulation in the expression of many genes that play essential roles in cell cycle regulation, which led to the identification of ATM signaling, G2/M DNA damage checkpoint, regulation by BTG family protein, and G1/S checkpoint as major influenced pathways during MPV infection. A core cell cycle regulation gene, Cdc25 kinase, has three essential homologs Cdc 25A/B/C that exhibited significant regulation upon MPV infection. While Cdc25B/C showed downregulation favoring cell arrest in G2 phase, Cdc2A exhibited upregulation, favoring S phase progression. The impact of this mode of cell cycle regulation on viral infection remains unknown. However, cell arrest in G2 phase was described in other viral infections including human immunodeficiency virus (HIV) and was found to be mainly mediated by viral protein R (Vpr) [91–93]. While many of the G2/M DNA damage checkpoint pathway genes are known to be modulated during HIV infection, Vpr seems to induce cell arrest by molecular mechanisms other than the classic DNA check point . Recently, evidence supporting a role for PP2A in Vpr-induced arrest has emerged, and was substantiated further by other studies in support of PP2A being a common target during infection with other viruses, including simian virus 40 (SV40), polyoma virus, human T lymphotrophic retrovirus and adenovirus . Our results showed significant downregulation in two PP2A isoforms, regulatory subunit B' gamma isoform (PPP2R5C) and protein phosphatase 2, regulatory subunit B' epsilon isoform (PPP2R5E), suggesting that the induction mechanisms of G2 arrest in MPV infection might be similar to those observed in other viruses. Because genetically diverse viruses seem to induce the same G2 arrest response in different infected cells, it is likely that this response has an important function and might be part of antiviral host defenses. While some of the viral genes eliciting this response are being identified as Vpr in HIV, and E4 of F4 and HTLV tax protein in adenoviruses, the MPV gene inducing this response remains unknown. Other important genes in cell cycle regulation showing expression favoring progression of cell cycle and arrest only in G2 phase include Rb, E2F, cyclins, BTG1, and BRCA1.
In this study we combined microarray with data mining and statistical analysis to identify important interfaces of host-pathogen interaction. Our results aligned nicely with previous reports carried out using viruses from the same or different genus, and provided new set of genes that play important roles in MPV infection. Further work is warranted to validate and examine the potential of these genes in antiviral therapies.
Using microarrays, we studied MPV-induced changes in gene expression of Macaca mulatta kidney epithelial cells to identify major host-virus interaction interfaces. Infection stimulated a marked modulation in some 2,702 host genes representing ≈ 5.7% of total interrogated host transcripts. The majority of genes (89.08%) underwent 1.5-folds downregulation or more. While downregulated genes exhibited a steady trend during the study, upregulated genes showed more time-dependent regulation intensity. Further data analysis showed that regulated genes cluster into distinctive functional classes, canonical pathways and networks that can be linked to established viral biogenesis. Our results introduce a set of host genes and novel pathways for further evaluation as targets for potential use in developing new antiviral therapies.
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
nuclear receptor coactivator 3
cAMP responsive element binding protein 1
YY1 transcription factor
histone deacetylase 2
F-box protein 11
protein arginine methyltransferase 3
MYST histone acetyltransferase 2
MYC binding protein 2
arginyl-tRNA synthetase 2, mitochondrial
NADPH oxidase activator
B-cell CLL/lymphoma 2
- BBC3 or PUMA:
BCL2 binding component 3
p21 protein (Cdc42/Rac)-activated kinase 2
cell division cycle 25
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ras homolog gene family, member B
ras homolog gene family, member Q
ras homolog gene family, member T1
Rho family GTPase 3
FYN oncogene related to SRC, FGR, YES
Rho Associated Kinase, Rho kinase
c-abl oncogene 1 or 2, receptor tyrosine kinase
actin related protein 2/3
actin-related protein 2/3 complex, subunit 5-like
GNAS complex locus
activating transcription factor 2
c-abl oncogene 1 receptor tyrosine kinase
breast cancer 1
B-cell translocation gene-1
Transforming growth factor β
glycogen synthase kinase β
ataxia telangiectasia mutated and rad3-related
- TRAIL or TNFSF10:
tumor necrosis factor (ligand) superfamily, member 10
Fas (TNF receptor superfamily, member 6)
cytokine response modifier A
Src family kinases
son of sevenless homolog 2
Protein Phosphatase Type2a
human T-cell leukemia virus
Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army.
Microarray data have been submitted to the Gene Expression Omnibus (GEO) and can be searched using the record ID: GSE21001.
- Breman JG, Kalisa R, Steniowski MV, Zanotto E, Gromyko AI, Arita I: Human monkeypox, 1970-79. Bull World Health Organ 1980, 58: 165-182.PubMedPubMed Central
- Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, et al.: A tale of two clades: monkeypox viruses. J Gen Virol 2005, 86: 2661-2672. 10.1099/vir.0.81215-0PubMedView Article
- Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z, Schriewer J, Buck C, Wang C, Lefkowitz EJ, et al.: Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005, 340: 46-63. 10.1016/j.virol.2005.05.030PubMedView Article
- Shchelkunov SN, Totmenin AV, Safronov PF, Mikheev MV, Gutorov VV, Ryazankina OI, Petrov NA, Babkin IV, Uvarova EA, Sandakhchiev LS, et al.: Analysis of the monkeypox virus genome. Virology 2002, 297: 172-194. 10.1006/viro.2002.1446PubMedView Article
- Carter GC, Law M, Hollinshead M, Smith GL: Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol 2005, 86: 1279-1290. 10.1099/vir.0.80831-0PubMedView Article
- Hsiao JC, Chung CS, Chang W: Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J Virol 1999, 73: 8750-8761.PubMedPubMed Central
- Chung CS, Hsiao JC, Chang YS, Chang W: A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol 1998, 72: 1577-1585.PubMedPubMed Central
- Lin CL, Chung CS, Heine HG, Chang W: Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J Virol 2000, 74: 3353-3365. 10.1128/JVI.74.7.3353-3365.2000PubMedPubMed CentralView Article
- Armstrong JA, Metz DH, Young MR: The mode of entry of vaccinia virus into L cells. J Gen Virol 1973, 21: 533-537. 10.1099/0022-1317-21-3-533PubMedView Article
- Dales S, Kajioka R: the cycle of multiplication of vaccinia virus in earle's strain l cells. I. Uptake and penetration. Virology 1964, 24: 278-294. 10.1016/0042-6822(64)90167-9PubMedView Article
- Payne LG, Norrby E: Adsorption and penetration of enveloped and naked vaccinia virus particles. J Virol 1978, 27: 19-27.PubMedPubMed Central
- Vanderplasschen A, Hollinshead M, Smith GL: Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol 1998,79(Pt 4):877-887.PubMedView Article
- Munyon W, Paoletti E, Grace JT Jr: RNA polymerase activity in purified infectious vaccinia virus. Proc Natl Acad Sci USA 1967, 58: 2280-2287. 10.1073/pnas.58.6.2280PubMedPubMed CentralView Article
- Kates JR, McAuslan BR: Poxvirus DNA-dependent RNA polymerase. Proc Natl Acad Sci USA 1967, 58: 134-141. 10.1073/pnas.58.1.134PubMedPubMed CentralView Article
- Da Fonseca F, Moss B: Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription. Proc Natl Acad Sci USA 2003, 100: 11291-11296. 10.1073/pnas.1534874100PubMedPubMed CentralView Article
- Werden SJ, Rahman MM, McFadden G: Poxvirus host range genes. Adv Virus Res 2008, 71: 135-171. full_textPubMedView Article
- McFadden G: Poxvirus tropism. Nat Rev Microbiol 2005, 3: 201-213. 10.1038/nrmicro1099PubMedPubMed CentralView Article
- Rubins KH, Hensley LE, Bell GW, Wang C, Lefkowitz EJ, Brown PO, Relman DA: Comparative Analysis of Viral Gene Expression Programs during Poxvirus Infection: A Transcriptional Map of the Vaccinia and Monkeypox Genomes. PLoS ONE 2008, 3: e2628. 10.1371/journal.pone.0002628PubMedPubMed CentralView Article
- Assarsson E, Greenbaum JA, Sundstrom M, Schaffer L, Hammond JA, Pasquetto V, Oseroff C, Hendrickson RC, Lefkowitz EJ, Tscharke DC, et al.: Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci USA 2008, 105: 2140-2145. 10.1073/pnas.0711573105PubMedPubMed CentralView Article
- Guerra S, Lopez-Fernandez LA, Pascual-Montano A, Munoz M, Harshman K, Esteban M: Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J Virol 2003, 77: 6493-6506. 10.1128/JVI.77.11.6493-6506.2003PubMedPubMed CentralView Article
- Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW, Owen A, Leduc JW, Brown PO, Relman DA: The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci USA 2004, 101: 15190-15195. 10.1073/pnas.0405759101PubMedPubMed CentralView Article
- Brum LM, Lopez MC, Varela JC, Baker HV, Moyer RW: Microarray analysis of A549 cells infected with rabbitpox virus (RPV): a comparison of wild-type RPV and RPV deleted for the host range gene, SPI-1. Virology 2003, 315: 322-334. 10.1016/S0042-6822(03)00532-4PubMedView Article
- Schuster FL, Visvesvara GS: Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals. J Clin Microbiol 1996, 34: 385-388.PubMedPubMed Central
- Tsuchiya Y, Tagaya I: Plaque assay of variola virus in a cynomolgus monkey kidney cell line. Arch Gesamte Virusforsch 1970, 32: 73-81. 10.1007/BF01241522PubMedView Article
- Hui EK, Yap EM, An DS, Chen IS, Nayak DP: Inhibition of influenza virus matrix (M1) protein expression and virus replication by U6 promoter-driven and lentivirus-mediated delivery of siRNA. J Gen Virol 2004, 85: 1877-1884. 10.1099/vir.0.79906-0PubMedView Article
- Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996, 14: 1675-1680. 10.1038/nbt1296-1675PubMedView Article
- Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005, 19: 1294-1305. 10.1101/gad.1304105PubMedPubMed CentralView Article
- Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288: 1053-1058. 10.1126/science.288.5468.1053PubMedView Article
- Nakajima W, Tanaka N: Synergistic induction of apoptosis by p53-inducible Bcl-2 family proteins Noxa and Puma. J Nippon Med Sch 2007, 74: 148-157. 10.1272/jnms.74.148PubMedView Article
- Debatin KM, Poncet D, Kroemer G: Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 2002, 21: 8786-8803. 10.1038/sj.onc.1206039PubMedView Article
- Pavlov EV, Priault M, Pietkiewicz D, Cheng EH, Antonsson B, Manon S, Korsmeyer SJ, Mannella CA, Kinnally KW: A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J Cell Biol 2001, 155: 725-731. 10.1083/jcb.200107057PubMedPubMed CentralView Article
- Shimizu S, Konishi A, Kodama T, Tsujimoto Y: BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci USA 2000, 97: 3100-3105. 10.1073/pnas.97.7.3100PubMedPubMed CentralView Article
- Bossy-Wetzel E, Green DR: Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999, 274: 17484-17490. 10.1074/jbc.274.25.17484PubMedView Article
- Edick MJ, Tesfay L, Lamb LE, Knudsen BS, Miranti CK: Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol Biol Cell 2007, 18: 2481-2490. 10.1091/mbc.E06-04-0261PubMedPubMed CentralView Article
- Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M, Knight RA, Green DR, Thompson C, Vousden KH: p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 2004, 279: 8076-8083. 10.1074/jbc.M307469200PubMedView Article
- Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68: 383-424. 10.1146/annurev.biochem.68.1.383PubMedView Article
- Orlowski RZ: The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 1999, 6: 303-313. 10.1038/sj.cdd.4400505PubMedView Article
- Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J: Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 2002, 21: 5911-5920. 10.1093/emboj/cdf567PubMedPubMed CentralView Article
- Lindqvist A, Kallstrom H, Lundgren A, Barsoum E, Rosenthal CK: Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol 2005, 171: 35-45. 10.1083/jcb.200503066PubMedPubMed CentralView Article
- Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H: Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277: 1501-1505. 10.1126/science.277.5331.1501PubMedView Article
- Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG: Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E. Oncogene 2002, 21: 291-298. 10.1038/sj.onc.1205025PubMedView Article
- Bales E, Mills L, Milam N, McGahren-Murray M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, et al.: The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Res 2005, 65: 692-697.PubMed
- Deane NG, Lee H, Hamaamen J, Ruley A, Washington MK, LaFleur B, Thorgeirsson SS, Price R, Beauchamp RD: Enhanced tumor formation in cyclin D1 × transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging. Cancer Res 2004, 64: 1315-1322. 10.1158/0008-5472.CAN-03-1772PubMedView Article
- Nakamoto M: Eph receptors and ephrins. Int J Biochem Cell Biol 2000, 32: 7-12. 10.1016/S1357-2725(99)00096-5PubMedView Article
- Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, et al.: Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 2007, 3: 89. 10.1038/msb4100134PubMedPubMed CentralView Article
- Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, D'Angelo M, Felici A, Sacchi A, Crescenzi M: Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle. Mol Cell Biol 2001, 21: 5631-5643. 10.1128/MCB.21.16.5631-5643.2001PubMedPubMed CentralView Article
- Siegert JL, Rushton JJ, Sellers WR, Kaelin WG Jr, Robbins PD: Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity. Oncogene 2000, 19: 5703-5711. 10.1038/sj.onc.1203966PubMedView Article
- King KL, Cidlowski JA: Cell cycle regulation and apoptosis. Annu Rev Physiol 1998, 60: 601-617. 10.1146/annurev.physiol.60.1.601PubMedView Article
- Martin LG, Demers GW, Galloway DA: Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol 1998, 72: 975-985.PubMedPubMed Central
- Hallstrom TC, Nevins JR: Balancing the decision of cell proliferation and cell fate. Cell Cycle 2009, 8: 532-535. 10.4161/cc.8.4.7609PubMedPubMed CentralView Article
- Roussel MF: The INK4 family of cell cycle inhibitors in cancer. Oncogene 1999, 18: 5311-5317. 10.1038/sj.onc.1202998PubMedView Article
- Kohn KW: Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol Biol Cell 1999, 10: 2703-2734.PubMedPubMed CentralView Article
- Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J: The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410: 842-847. 10.1038/35071124PubMedView Article
- Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J, Lukas J: Rapid destruction of human Cdc25A in response to DNA damage. Science 2000, 288: 1425-1429. 10.1126/science.288.5470.1425PubMedView Article
- Lew J: MAP kinases and CDKs: kinetic basis for catalytic activation. Biochemistry 2003, 42: 849-856. 10.1021/bi0269761PubMedView Article
- Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13: 1501-1512. 10.1101/gad.13.12.1501PubMedView Article
- Donovan JC, Rothenstein JM, Slingerland JM: Non-malignant and tumor-derived cells differ in their requirement for p27Kip1 in transforming growth factor-beta-mediated G1 arrest. J Biol Chem 2002, 277: 41686-41692. 10.1074/jbc.M204307200PubMedView Article
- Manoukian AS, Woodgett JR: Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 2002, 84: 203-229. full_textPubMedView Article
- Sakamoto K, Creamer BA, Triplett AA, Wagner KU: The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells. Mol Endocrinol 2007, 21: 1877-1892. 10.1210/me.2006-0316PubMedView Article
- Goldstone S, Pavey S, Forrest A, Sinnamon J, Gabrielli B: Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene 2001, 20: 921-932. 10.1038/sj.onc.1204177PubMedView Article
- Kumagai A, Dunphy WG: The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell 1991, 64: 903-914. 10.1016/0092-8674(91)90315-PPubMedView Article
- Lavin MF, Shiloh Y: The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997, 15: 177-202. 10.1146/annurev.immunol.15.1.177PubMedView Article
- Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998, 281: 1677-1679. 10.1126/science.281.5383.1677PubMedView Article
- Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL, Friend SH: Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J 1998, 17: 159-169. 10.1093/emboj/17.1.159PubMedPubMed CentralView Article
- Zhao H, Piwnica-Worms H: ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001, 21: 4129-4139. 10.1128/MCB.21.13.4129-4139.2001PubMedPubMed CentralView Article
- Bahassi el M, Conn CW, Myer DL, Hennigan RF, McGowan CH, Sanchez Y, Stambrook PJ: Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene 2002, 21: 6633-6640. 10.1038/sj.onc.1205850PubMedView Article
- Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ: Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277: 1497-1501. 10.1126/science.277.5331.1497PubMedView Article
- Hengartner MO: The biochemistry of apoptosis. Nature 2000, 407: 770-776. 10.1038/35037710PubMedView Article
- Everett H, McFadden G: Poxviruses and apoptosis: a time to die. Curr Opin Microbiol 2002, 5: 395-402. 10.1016/S1369-5274(02)00340-5PubMedView Article
- Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, et al.: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386: 517-521. 10.1038/386517a0PubMedView Article
- Shisler JL, Senkevich TG, Berry MJ, Moss B: Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science 1998, 279: 102-105. 10.1126/science.279.5347.102PubMedView Article
- Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP, Salvesen G: Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 1994, 269: 19331-19337.PubMed
- Quan LT, Caputo A, Bleackley RC, Pickup DJ, Salvesen GS: Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem 1995, 270: 10377-10379. 10.1074/jbc.270.52.31046PubMedView Article
- Dobbelstein M, Shenk T: Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J Virol 1996, 70: 6479-6485.PubMedPubMed Central
- Davies MV, Chang HW, Jacobs BL, Kaufman RJ: The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J Virol 1993, 67: 1688-1692.PubMedPubMed Central
- Wasilenko ST, Stewart TL, Meyers AF, Barry M: Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc Natl Acad Sci USA 2003, 100: 14345-14350. 10.1073/pnas.2235583100PubMedPubMed CentralView Article
- Parrino J, Hotchkiss RS, Bray M: Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections. Emerg Infect Dis 2007, 13: 191-198. 10.3201/eid1302.060963PubMedPubMed CentralView Article
- Afonso CL, Tulman ER, Lu Z, Zsak L, Kutish GF, Rock DL: The genome of fowlpox virus. J Virol 2000, 74: 3815-3831. 10.1128/JVI.74.8.3815-3831.2000PubMedPubMed CentralView Article
- Soloski MJ, Holowczak JA: Characterization of supercoiled nucleoprotein complexes released from detergent-treated vaccinia virions. J Virol 1981, 37: 770-783.PubMedPubMed Central
- Puvion-Dutilleul F, Leduc EH, Puvion E: The osmium ammine-SO2 staining method for studying the in situ configuration of viral genomes in ultrathin sections of DNA virus infected cells. Biol Cell 1996, 87: 133-141. 10.1016/S0248-4900(97)89270-2PubMedView Article
- Lilley CE, Chaurushiya MS, Weitzman MD: Chromatin at the intersection of viral infection and DNA damage. Biochim Biophys Acta 2009, 1799: 319-327.PubMedPubMed CentralView Article
- Fanning E, Zhao K: SV40 DNA replication: from the A gene to a nanomachine. Virology 2009, 384: 352-359. 10.1016/j.virol.2008.11.038PubMedPubMed CentralView Article
- Scaife RM, Job D, Langdon WY: Rapid microtubule-dependent induction of neurite-like extensions in NIH 3T3 fibroblasts by inhibition of ROCK and Cbl. Mol Biol Cell 2003, 14: 4605-4617. 10.1091/mbc.E02-11-0739PubMedPubMed CentralView Article
- McGlade J, Brunkhorst B, Anderson D, Mbamalu G, Settleman J, Dedhar S, Rozakis-Adcock M, Chen LB, Pawson T: The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. EMBO J 1993, 12: 3073-3081.PubMedPubMed Central
- Pawlak G, Helfman DM: Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol Biol Cell 2002, 13: 336-347. 10.1091/mbc.01-06-0302PubMedPubMed CentralView Article
- Giancotti FG, Ruoslahti E: Integrin signaling. Science 1999, 285: 1028-1032. 10.1126/science.285.5430.1028PubMedView Article
- Pochynyuk O, Stockand JD, Staruschenko A: Ion channel regulation by Ras, Rho, and Rab small GTPases. Exp Biol Med (Maywood) 2007, 232: 1258-1265. 10.3181/0703-MR-76View Article
- Everett H, Barry M, Sun X, Lee SF, Frantz C, Berthiaume LG, McFadden G, Bleackley RC: The myxoma poxvirus protein, M11L, prevents apoptosis by direct interaction with the mitochondrial permeability transition pore. J Exp Med 2002, 196: 1127-1139. 10.1084/jem.20011247PubMedPubMed CentralView Article
- Schubert U, Ferrer-Montiel AV, Oblatt-Montal M, Henklein P, Strebel K, Montal M: Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett 1996, 398: 12-18. 10.1016/S0014-5793(96)01146-5PubMedView Article
- Desai SA, Bezrukov SM, Zimmerberg J: A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature 2000, 406: 1001-1005. 10.1038/35023000PubMedView Article
- Hrimech M, Yao XJ, Branton PE, Cohen EA: Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. EMBO J 2000, 19: 3956-3967. 10.1093/emboj/19.15.3956PubMedPubMed CentralView Article
- He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR: Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995, 69: 6705-6711.PubMedPubMed Central
- Re F, Braaten D, Franke EK, Luban J: Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol 1995, 69: 6859-6864.PubMedPubMed Central
- Zhao RY, Elder RT: Viral infections and cell cycle G2/M regulation. Cell Res 2005, 15: 143-149. 10.1038/sj.cr.7290279PubMedView Article
- Janssens V, Goris J: Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001, 353: 417-439. 10.1042/0264-6021:3530417PubMedPubMed CentralView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.